HOXA10 drives immune evasion in early lung adenocarcinoma by recruiting immunosuppressive macrophages via NF-κB/CCL2 signaling.

Ma J, Xu X, Zhu J, Wang J, Wang L, Liu Y, Qiu W

Open source

DOI
10.1186/s13046-026-03679-6
Published
2026 Feb 25
Container
Journal of experimental & clinical cancer research : CR
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13046-026-03679-6,
  title = {HOXA10 drives immune evasion in early lung adenocarcinoma by recruiting immunosuppressive macrophages via NF-κB/CCL2 signaling.},
  author = {Ma J and Xu X and Zhu J and Wang J and Wang L and Liu Y and Qiu W},
  year = {2026},
  journal = {Journal of experimental \& clinical cancer research : CR},
  doi = {10.1186/s13046-026-03679-6},
  url = {https://doi.org/10.1186/s13046-026-03679-6}
}

RIS

TY  - JOUR
TI  - HOXA10 drives immune evasion in early lung adenocarcinoma by recruiting immunosuppressive macrophages via NF-κB/CCL2 signaling.
AU  - Ma J
AU  - Xu X
AU  - Zhu J
AU  - Wang J
AU  - Wang L
AU  - Liu Y
AU  - Qiu W
PY  - 2026
JO  - Journal of experimental & clinical cancer research : CR
DO  - 10.1186/s13046-026-03679-6
UR  - https://doi.org/10.1186/s13046-026-03679-6
ER  - 

APA

J, M., X, X., J, Z., J, W., L, W., Y, L., & W, Q. (2026). HOXA10 drives immune evasion in early lung adenocarcinoma by recruiting immunosuppressive macrophages via NF-κB/CCL2 signaling.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-026-03679-6

Source records